Immunocore Announces Start of Phase I ImmTAC® Study in Patients with Solid Tumours
PRESS RELEASE Immunocore Announces Start of Phase I ImmTAC® Study in Patients with Solid Tumours Study of IMCnyeso in NSCLC, Bladder Cancer, Melanoma and Synovial Sarcoma is the first in GSK collaboration (Oxford, UK and Conshohocken, US, 20 August 2018) …